Your browser does not support JavaScript!
http://iet.metastore.ingenta.com
1887

access icon free Acute and subacute toxicity studies of Pluronic P85/poly (lactic acid) nanoparticles in mice

The objective of the present reported study was to evaluate the oral toxicity of poly (lactic acid)-b-Pluronic-b-poly (lactic acid) (PLA-P85-PLA) nanoparticles (NPs) so as to demonstrate their applicability for drug delivery applications. In acute oral toxicity studies, the animals were fed with 0.4 ml PLA-P85-PLA NPs solution in different concentrations (low concentration: 20 mg/l, intermediate concentration: 100 mg/l and higher concentration: 500 mg/l) for 14 days; no deaths or treatment related complications were observed even in the higher concentration treatment. In case of the subacute oral toxicity test, the NPs were administered orally to mice for a period of 28 days. At the end of the study, blood samples were collected for biochemical analysis. For histopathological analysis, organs of the animals were weighed and processed. All the animals survived during the study, with no significant changes in clinical signs, body weight, feed consumption, biochemistry parameters, organ weights and histopathological findings. These results demonstrate that PLA-P85-PLA NPs produced no treatment related toxicity in mice following oral administration, thus, they can be exploited for potential therapeutic applications.

References

    1. 1)
      • 17. Pokharkar, V., Dhar, S., Bhumkar, D., Mali, V., Bodhankar, S., Prasad, B.L.: ‘Acute and subacute toxicity studies of chitosan reduced gold nanoparticles: a novel carrier for therapeutic agents’, J. Biomed. Nanotechnol., 2009, 5, (3), pp. 233239 (doi: 10.1166/jbn.2009.1027).
    2. 2)
      • 3. Panyam, J., Labhasetwar, V.: ‘Biodegradable nanoparticles for drug and gene delivery to cells and tissue’, Adv. Drug Deliv. Rev., 2003, 55, (3), pp. 329347 (doi: 10.1016/S0169-409X(02)00228-4).
    3. 3)
      • 14. Shimpi, N., Borane, M., Mishra, S., Kadam, M.: ‘Biodegradation of polystyrene (PS)-poly(lactic acid) (PLA) nanocomposites using Pseudomonas aeruginosa’, Macromol. Res., 2012, 20, (2), pp. 181187 (doi: 10.1007/s13233-012-0026-1).
    4. 4)
      • 10. Smith, A.M., Duan, H., Mohs, A.M., Nie, S.: ‘Bioconjugated quantum dots for in vivo molecular and cellular imaging’, Adv. Drug Deliv. Rev., 2008, 60, (11), pp. 12261240 (doi: 10.1016/j.addr.2008.03.015).
    5. 5)
      • 6. Pritz, C.O., Dudas, J., Rask-Andersen, H., Schrott-Fischer, A., Glueckert, R.: ‘Nanomedicine strategies for drug delivery to the ear’, Nanomedicine, 2013, 8, (7), pp. 11551172 (doi: 10.2217/nnm.13.104).
    6. 6)
      • 5. Kim, J.Y., Choi, W.I., Kim, Y.H., et al: ‘In-vivo tumor targeting of pluronic-based nano-carriers’, J. Control Release, 2010, 147, (1), pp. 109117 (doi: 10.1016/j.jconrel.2010.06.010).
    7. 7)
      • 20. Carvalho, A.L., Annoni, R., Silva, P.R., et al: ‘Acute, subacute toxicity and mutagenic effects of anacardic acids from cashew (Anacardium occidentale Linn.) in mice’, J. Ethnopharmacol., 2011, 135, (3), pp. 730736 (doi: 10.1016/j.jep.2011.04.002).
    8. 8)
      • 13. Madhavan Nampoothiri, K., Nair, N.R., John, R.P.: ‘An overview of the recent developments in polylactide (PLA) research’, Bioresour. Technol., 2010, 101, (22), pp. 84938501 (doi: 10.1016/j.biortech.2010.05.092).
    9. 9)
      • 1. Zhang, L., Webster, T.J.: ‘Nanotechnology and nanomaterials: promises for improved tissue regeneration’, Nano. Today, 2009, 4, pp. 6680 (doi: 10.1016/j.nantod.2008.10.014).
    10. 10)
      • 19. Dhawan, A., Sharma, V.: ‘Toxicity assessment of nanomaterials: methods and challenges’, Anal. Bioanal. Chem., 2010, 398, (2), pp. 589605 (doi: 10.1007/s00216-010-3996-x).
    11. 11)
      • 2. Vega-villa, K.R., Takemoto, J.K., Yanez, J.A., Remsberg, C.M., Forrest, M.L., Davies, N.M.: ‘Clinical toxicities of nanocarrier systems’, Adv. Drug Deliv. Rev., 2008, 60, (8), pp. 929938 (doi: 10.1016/j.addr.2007.11.007).
    12. 12)
      • 8. Shim, M.S., Kwon, Y.J.: ‘Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications’, Adv. Drug Deliv. Rev., 2012, 64, (11), pp. 10461059 (doi: 10.1016/j.addr.2012.01.018).
    13. 13)
      • 4. Semete, B., Booysen, L., Lemmer, Y., et al: ‘In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems’, Nanomedicine, 2010, 6, (5), pp. 662671 (doi: 10.1016/j.nano.2010.02.002).
    14. 14)
      • 11. Pan, J., Feng, S.S.: ‘Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers’, Biomaterials, 2009, 30, (6), pp. 11761183 (doi: 10.1016/j.biomaterials.2008.10.039).
    15. 15)
      • 7. Stadler, A., Chi, C., Van der Lelie, D., Gang, O.: ‘DNA-incorporating nanomaterials in biotechnological applications’, Nanomedicine, 2010, 5, (2), pp. 319334 (doi: 10.2217/nnm.10.2).
    16. 16)
      • 18. Jones, C.F., Grainger, D.W.: ‘In vitro assessments of nanomaterial toxicity’, Adv. Drug. Deliv. Rev., 2009, 61, (6), pp. 438456 (doi: 10.1016/j.addr.2009.03.005).
    17. 17)
      • 15. Gebhart, C.L., Sriadibhatla, S., Vinogradov, S., Lemieux, P., Alakhov, V., Kabanov, A.V.: ‘Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer’, Bioconjug. Chem., 2002, 13, (5), pp. 937944 (doi: 10.1021/bc025504w).
    18. 18)
      • 12. Xiong, X.Y., Li, Q.H., Li, Y.P., Guo, L., Li, Z.L., Gong, Y.C.: ‘Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery’, Colloids. Surf. B, Biointerfaces, 2013, 111C, pp. 282288 (doi: 10.1016/j.colsurfb.2013.06.019).
    19. 19)
      • 9. Lu, J., Liong, M., Li, Z., Zink, J.I., Tamanoi, F.: ‘Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals’, Small, 2010, 6, (16), pp. 17941805 (doi: 10.1002/smll.201000538).
    20. 20)
      • 16. Xiong, X.Y., Tam, K.C., Gan, L.H.: ‘Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles’, J. Control Release, 2005, 103, (1), pp. 7382 (doi: 10.1016/j.jconrel.2004.11.018).
http://iet.metastore.ingenta.com/content/journals/10.1049/mnl.2013.0461
Loading

Related content

content/journals/10.1049/mnl.2013.0461
pub_keyword,iet_inspecKeyword,pub_concept
6
6
Loading
This is a required field
Please enter a valid email address